NasdaqCM - Nasdaq Real Time Price USD
Aethlon Medical, Inc. (AEMD)
0.4100
-0.0049
(-1.18%)
At close: May 20 at 4:00:01 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
0
0
574.2450
294.1650
659.1040
Operating Expense
9,823.3760
12,636.5680
12,472.8830
10,715.0500
8,550.6030
Operating Income
-9,823.3760
-12,636.5680
-11,898.6380
-10,420.8850
-7,891.4990
Net Non Operating Interest Income Expense
264.7620
428.3940
10.9730
0
-1.5800
Other Income Expense
--
--
-142.1210
--
--
Pretax Income
-9,558.6140
-12,208.1740
-12,029.7860
-10,420.8850
-7,891.4990
Net Income Common Stockholders
-9,558.6140
-12,208.1740
-12,029.7860
-10,416.0910
-7,886.7090
Diluted NI Available to Com Stockholders
-9,558.6140
-12,208.1740
-12,029.7860
-10,416.0910
-7,886.7090
Basic EPS
-1.52
-4.86
-5.90
-7.10
-6.50
Diluted EPS
-1.52
-4.86
-5.90
-7.10
-6.50
Basic Average Shares
9,506.0540
2,512.7740
2,053.7430
1,475.6960
1,209.0880
Diluted Average Shares
9,506.0540
2,512.7740
2,053.7430
1,475.6960
1,209.0880
Total Operating Income as Reported
-9,823.3760
-12,636.5680
-11,898.6380
-10,420.8850
-7,891.4990
Total Expenses
9,823.3760
12,636.5680
12,472.8830
10,715.0500
8,550.6030
Net Income from Continuing & Discontinued Operation
-9,558.6140
-12,208.1740
-12,029.7860
-10,416.0910
-7,886.7090
Normalized Income
-9,558.6140
-12,208.1740
-11,887.6650
-10,416.0910
-7,886.7090
Interest Income
264.7620
428.3940
10.9730
0
--
Interest Expense
--
--
--
--
1.5800
Net Interest Income
264.7620
428.3940
10.9730
0
-1.5800
EBIT
-9,823.3760
-12,636.5680
-11,898.6380
-10,420.8850
-7,891.4990
EBITDA
-9,481.8490
-12,277.5110
-11,657.7460
-10,297.2000
-7,851.5600
Reconciled Depreciation
341.5270
359.0570
240.8920
123.6850
39.9390
Net Income from Continuing Operation Net Minority Interest
-9,558.6140
-12,208.1740
-12,029.7860
-10,416.0910
-7,886.7090
Total Unusual Items Excluding Goodwill
0
0
-142.1210
0
0
Total Unusual Items
0
0
-142.1210
0
0
Normalized EBITDA
-9,481.8490
-12,277.5110
-11,515.6250
-10,297.2000
-7,851.5600
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
3/31/2021 - 3/4/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DHAI DIH Holding US, Inc.
0.2340
+3.45%
VTAK Catheter Precision, Inc.
0.2799
-1.79%
HSDT Helius Medical Technologies, Inc.
4.5900
-6.13%
CODX Co-Diagnostics, Inc.
0.2750
-3.54%
AIMD Ainos, Inc.
0.5290
+0.19%
AXDX Accelerate Diagnostics, Inc.
0.0340
0.00%
AMIX Autonomix Medical, Inc.
1.7900
-4.28%
CTSO Cytosorbents Corporation
0.8402
-1.16%
OPGN OpGen, Inc.
4.8900
+3.16%
TIVC Tivic Health Systems, Inc.
4.4500
+3.73%